HRCM
IART icon

Hood River Capital Management’s Integra LifeSciences IART Stock Holding History

Hood River Capital Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-258,975
Closed -$17.3M – 156
2021
Q4 		$17.3M Sell
258,975
-160,352
-38% -$10.8M 0.52% 66
2021
Q3 		$28.7M Sell
419,327
-13,497
-3% -$954K 0.89% 39
2021
Q2 		$29.5M Sell
432,824
-6,907
-2% -$488K 0.88% 44
2021
Q1 		$30.4M Sell
439,731
-43,082
-9% -$2.92M 0.98% 38
2020
Q4 		$31.3M Buy
482,813
+8,282
+2% +$446K 1.04% 40
2020
Q3 		$22.4M Sell
474,531
-281
-0.1% -$13.4K 0.97% 40
2020
Q2 		$22.3M Buy
474,812
+68,671
+17% +$3.38M 1% 40
2020
Q1 		$18.1M Sell
406,141
-461,652
-53% -$24.2M 1.04% 39
2019
Q4 		$50.6M Buy
867,793
+63,559
+8% +$3.78M 2.18% 8
2019
Q3 		$48.3M Buy
804,234
+202,008
+34% +$12M 2.47% 7
2019
Q2 		$33.6M Buy
602,226
+421,454
+233% +$21.7M 1.58% 23
2019
Q1 		$10.1M Sell
180,772
-16,480
-8% -$839K 0.51% 75
2018
Q4 		$8.9M Buy
197,252
+11,500
+6% +$631K 0.52% 74
2018
Q3 		$12.2M Buy
185,752
+8,687
+5% +$540K 0.54% 75
2018
Q2 		$11.4M Buy
+177,065
New +$11M 0.59% 76
2017
Q4 		– Sell
-293,179
Closed -$14.8M – 95
2017
Q3 		$14.8M Sell
293,179
-384,106
-57% -$19.7M 0.94% 48
2017
Q2 		$36.9M Sell
677,285
-114,660
-14% -$5.48M 2.55% 5
2017
Q1 		$33.4M Buy
791,945
+27,041
+4% +$1.16M 2.5% 6
2016
Q4 		$32.8M Buy
764,904
+122,914
+19% +$5M 2.86% 7
2016
Q3 		$26.5M Buy
641,990
+227,550
+55% +$9.53M 2.72% 6
2016
Q2 		$16.5M Buy
414,440
+130,154
+46% +$4.68M 2.21% 7
2016
Q1 		$9.57M Sell
284,286
-5,326
-2% -$166K 1.28% 32
2015
Q4 		$9.81M Buy
289,612
+119,416
+70% +$3.73M 1.26% 33
2015
Q3 		$5.07M Buy
+170,196
New +$5.32M 0.7% 60

Other funds holding IART

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Hood River Capital Management's IART Position: Q1 2022 in Review

Hood River Capital Management sold out of Integra LifeSciences (IART) in Q1 2022, closing a stake of 258,975 shares — an estimated $17.3M sold.

Hood River Capital Management first reported a position in IART in Q3 2015 and held it in 24 quarters. The position peaked at $50.6M in Q4 2019. 278 funds tracked by Wall St. Rank hold IART as of Q1 2022.

  • Hood River Capital Management reported no remaining Integra LifeSciences position as of Q1 2022 after selling out during the quarter.
  • Hood River Capital Management sold 258,975 Integra LifeSciences shares in Q1 2022, an estimated $17.3M.
  • Hood River Capital Management first reported a position in Integra LifeSciences in Q3 2015 and held it in 24 quarters.
  • Hood River Capital Management's Integra LifeSciences position peaked at $50.6M in Q4 2019.
  • 278 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2022.

Based on Hood River Capital Management's 13F filing for Q1 2022, filed 16 May 2022.